A synthetic porcine reproductive and respiratory syndrome virus strain confers unprecedented levels of heterologous protection

Hiep L Vu, Fangrui Ma, William W. Laegreid, Asit K Pattnaik, David J Steffen, Alan R Doster, Fernando A. Osorio

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Current vaccines do not provide sufficient levels of protection against divergent porcine reproductive and respiratory syndrome virus (PRRSV) strains circulating in the field, mainly due to the substantial variation of the viral genome. We describe here a novel approach to generate a PRRSV vaccine candidate that could confer unprecedented levels of heterologous protection against divergent PRRSV isolates. By using a set of 59 nonredundant, full-genome sequences of type 2 PRRSVs, a consensus genome (designated PRRSV-CON) was generated by aligning these 59 PRRSV full-genome sequences, followed by selecting the most common nucleotide found at each position of the alignment. Next, the synthetic PRRSV-CON strain was generated through the use of reverse genetics. PRRSV-CON replicates as efficiently as our prototype PRRSV strain FL12, both in vitro and in vivo. Importantly, when inoculated into pigs, PRRSV-CON confers significantly broader levels of heterologous protection than does wild-type PRRSV. Collectively, our data demonstrate that PRRSV-CON can serve as an excellent candidate for the development of a broadly protective PRRSV vaccine.

Original languageEnglish (US)
Pages (from-to)12070-12083
Number of pages14
JournalJournal of virology
Volume89
Issue number23
DOIs
StatePublished - Jan 1 2015

Fingerprint

Porcine respiratory and reproductive syndrome virus
Porcine reproductive and respiratory syndrome virus
genome
Vaccines
Genome
vaccines
Reverse Genetics
Viral Genome
prototypes

ASJC Scopus subject areas

  • Microbiology
  • Immunology
  • Insect Science
  • Virology

Cite this

A synthetic porcine reproductive and respiratory syndrome virus strain confers unprecedented levels of heterologous protection. / Vu, Hiep L; Ma, Fangrui; Laegreid, William W.; Pattnaik, Asit K; Steffen, David J; Doster, Alan R; Osorio, Fernando A.

In: Journal of virology, Vol. 89, No. 23, 01.01.2015, p. 12070-12083.

Research output: Contribution to journalArticle

@article{fcb77224924a467bb5f5429ae5877f46,
title = "A synthetic porcine reproductive and respiratory syndrome virus strain confers unprecedented levels of heterologous protection",
abstract = "Current vaccines do not provide sufficient levels of protection against divergent porcine reproductive and respiratory syndrome virus (PRRSV) strains circulating in the field, mainly due to the substantial variation of the viral genome. We describe here a novel approach to generate a PRRSV vaccine candidate that could confer unprecedented levels of heterologous protection against divergent PRRSV isolates. By using a set of 59 nonredundant, full-genome sequences of type 2 PRRSVs, a consensus genome (designated PRRSV-CON) was generated by aligning these 59 PRRSV full-genome sequences, followed by selecting the most common nucleotide found at each position of the alignment. Next, the synthetic PRRSV-CON strain was generated through the use of reverse genetics. PRRSV-CON replicates as efficiently as our prototype PRRSV strain FL12, both in vitro and in vivo. Importantly, when inoculated into pigs, PRRSV-CON confers significantly broader levels of heterologous protection than does wild-type PRRSV. Collectively, our data demonstrate that PRRSV-CON can serve as an excellent candidate for the development of a broadly protective PRRSV vaccine.",
author = "Vu, {Hiep L} and Fangrui Ma and Laegreid, {William W.} and Pattnaik, {Asit K} and Steffen, {David J} and Doster, {Alan R} and Osorio, {Fernando A.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1128/JVI.01657-15",
language = "English (US)",
volume = "89",
pages = "12070--12083",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "23",

}

TY - JOUR

T1 - A synthetic porcine reproductive and respiratory syndrome virus strain confers unprecedented levels of heterologous protection

AU - Vu, Hiep L

AU - Ma, Fangrui

AU - Laegreid, William W.

AU - Pattnaik, Asit K

AU - Steffen, David J

AU - Doster, Alan R

AU - Osorio, Fernando A.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Current vaccines do not provide sufficient levels of protection against divergent porcine reproductive and respiratory syndrome virus (PRRSV) strains circulating in the field, mainly due to the substantial variation of the viral genome. We describe here a novel approach to generate a PRRSV vaccine candidate that could confer unprecedented levels of heterologous protection against divergent PRRSV isolates. By using a set of 59 nonredundant, full-genome sequences of type 2 PRRSVs, a consensus genome (designated PRRSV-CON) was generated by aligning these 59 PRRSV full-genome sequences, followed by selecting the most common nucleotide found at each position of the alignment. Next, the synthetic PRRSV-CON strain was generated through the use of reverse genetics. PRRSV-CON replicates as efficiently as our prototype PRRSV strain FL12, both in vitro and in vivo. Importantly, when inoculated into pigs, PRRSV-CON confers significantly broader levels of heterologous protection than does wild-type PRRSV. Collectively, our data demonstrate that PRRSV-CON can serve as an excellent candidate for the development of a broadly protective PRRSV vaccine.

AB - Current vaccines do not provide sufficient levels of protection against divergent porcine reproductive and respiratory syndrome virus (PRRSV) strains circulating in the field, mainly due to the substantial variation of the viral genome. We describe here a novel approach to generate a PRRSV vaccine candidate that could confer unprecedented levels of heterologous protection against divergent PRRSV isolates. By using a set of 59 nonredundant, full-genome sequences of type 2 PRRSVs, a consensus genome (designated PRRSV-CON) was generated by aligning these 59 PRRSV full-genome sequences, followed by selecting the most common nucleotide found at each position of the alignment. Next, the synthetic PRRSV-CON strain was generated through the use of reverse genetics. PRRSV-CON replicates as efficiently as our prototype PRRSV strain FL12, both in vitro and in vivo. Importantly, when inoculated into pigs, PRRSV-CON confers significantly broader levels of heterologous protection than does wild-type PRRSV. Collectively, our data demonstrate that PRRSV-CON can serve as an excellent candidate for the development of a broadly protective PRRSV vaccine.

UR - http://www.scopus.com/inward/record.url?scp=84949665736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949665736&partnerID=8YFLogxK

U2 - 10.1128/JVI.01657-15

DO - 10.1128/JVI.01657-15

M3 - Article

C2 - 26401031

AN - SCOPUS:84949665736

VL - 89

SP - 12070

EP - 12083

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 23

ER -